Women in the UK are being advised to consult their general practitioners or pharmacists if their usual hormone replacement therapy (HRT) prescriptions are disrupted by ongoing supply shortages. Health authorities have issued a clear warning against self-medicating or attempting to manage menopause symptoms without professional guidance.
The Department of Health confirmed that supplies of two major HRT patch brands have been affected by manufacturing and distribution delays. The affected products include Estradot transdermal patches and FemSeven Conti patches. Serious shortage protocols have been activated for Estradot transdermal patches, allowing pharmacists to supply alternative products without a new prescription until January 2027.
Guidance on Substituting Medications
Pharmacy manager Paul Irvine, based in Belfast, emphasized that many women become accustomed to specific brands of HRT. Switching brands can lead to side effects or reduced effectiveness, which is why professional advice is critical. Irvine noted that pharmacists are positioned to guide patients toward suitable alternatives and provide the correct dosage information.
Dr. Ursula Mason, chair of the Royal College of General Practitioners in Northern Ireland, acknowledged that finding a substitute can cause significant anxiety for patients who have found a preparation that works well for them. She assured patients that substitution protocols only allow for products with the exact same active ingredient and dose. If a new formulation causes side effects or fails to manage symptoms, patients are urged to contact their GP immediately.
Impact on Patient Wellbeing
Roisin Hillman, co-founder of Menopause Together, a support charity in Northern Ireland, highlighted the frustration many women feel when forced to switch brands. She reported that some women have experienced physical issues such as itchy skin or patches failing to adhere properly. Hillman described the situation as deeply frustrating, noting that once a woman finds a medication that supports her mental and physical health, it often falls into short supply.
Hillman advised women to request longer-term prescriptions from their GPs to stay ahead of potential supply gaps. She also strongly discouraged sharing HRT medications, as what is prescribed to one person may not be suitable for another. The emotional toll of these shortages is significant, with many women experiencing fear and anxiety about losing access to treatments that help them manage daily life.
The Department of Health has issued communications to healthcare professionals regarding the affected products, including advice on suitable alternatives that remain available. A spokesperson reiterated that patients who cannot access their prescribed medication or have concerns about an alternative should speak to a healthcare professional for advice about their treatment options.
Source: BBC
